Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 7:14:03029.
doi: 10.7189/jogh.14.03029.

Excessive active pharmaceutical ingredients in substandard and falsified drugs should also raise concerns in low-income countries

Affiliations
Review

Excessive active pharmaceutical ingredients in substandard and falsified drugs should also raise concerns in low-income countries

Elisa M Maffioli et al. J Glob Health. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and disclose no relevant interests.

Similar articles

References

    1. World Health Organization. WHO global surveillance and monitoring system for substandard and falsified medical products. Geneva: World Health Organization; 2017. Available: https://www.who.int/publications/i/item/9789241513425. Accessed: 29 March 2024.
    1. Newton PN, Lee SJ, Goodman C, Fernández FM, Yeung S, Phanouvong S, et al. Guidelines for Field Surveys of the Quality of Medicines: A Proposal. PLoS Med. 2009;6:e52. 10.1371/journal.pmed.1000052 - DOI - PMC - PubMed
    1. Infectious Diseases Data Observatory. Medicine Quality Scientific Literature Surveyor methodology. 2024. Available: https://www.iddo.org/mq-scientific-literature-surveyor-methodology. Accessed: 29 March 2024.
    1. Ozawa S, Evans DR, Bessias S, Haynie DG, Yemeke TT, Laing SK, et al. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. JAMA Netw Open. 2018;1:e181662. 10.1001/jamanetworkopen.2018.1662 - DOI - PMC - PubMed
    1. Webb S.A bitter pill to swallow: The problem of, and solutions to, Sub-Saharan Africa’s counterfeit pharmaceutical trade. The Columbia University Journal of Global Health. 2014;4:19–25.